News Releases

Nu Skin Enterprises To Present At RBC Capital Markets Consumer And Retail Conference

PROVO, Utah, May 24, 2018 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced Chief Financial Officer Mark Lawrence will present at the RBC Capital Markets Consumer and Retail Conference in Boston on Wednesday, May 30, 2018. 

Nu Skin Enterprises, Inc. logo (PRNewsFoto/Nu Skin Enterprises, Inc.)

The company's fireside chat will be webcast live beginning at 10 a.m. ET. Those wishing to access the audio can visit the Nu Skin Investor Relations page at ir.nuskin.com. The archive of the webcast will be available at this same location through Wednesday, June 13.   

About Nu Skin Enterprises, Inc.
Founded more than 30 years ago, Nu Skin Enterprises, Inc. develops and distributes innovative consumer products, offering a comprehensive line of premium-quality beauty and wellness solutions. The company builds upon its scientific expertise in both skin care and nutrition to continually develop innovative product brands that include the Nu Skin® personal care brand, the Pharmanex® nutrition brand, and most recently, the ageLOC® anti-aging brand. The ageLOC brand has generated a loyal following for such products as the ageLOC Youth nutritional supplement, the ageLOC Me® customized skin care system, as well as the ageLOC TR90® weight management and body shaping system. Nu Skin sells its products through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific. As a long-standing member of direct selling associations globally, Nu Skin is committed to the industry's consumer guidelines that protect and support those who sell and purchase its products through the direct selling channel. Nu Skin is also traded on the New York Stock Exchange under the symbol "NUS." More information is available at nuskin.com.

Nu Skin Social Media Channels
fb.com/nuskin  twitter.com/nuskin  instagram.com/nuskin

 

SOURCE Nu Skin Enterprises, Inc.

For further information: Media, media@nuskin.com, (801) 345-6397, or Investors, investorrelations@nuskin.com, (801) 345-3577­­­